Sign in

Private company

DA32 Life Science Tech Acquisition Corp.

American blank check company, incorporated in Delaware1

In its 2023 annual report the company says: “We are a Delaware blank check company incorporated on April 16, 2021 formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us.”30 It is headquartered in New York, New York.1

Last updated Oct 21, 2026.

Overview

$599.2KNet income, fiscal 20222
  • IndustryBlank Checks1
  • HeadquartersNew York, New York1
  • Incorporated inDE3
  • Business address345 Park Avenue South, 12Th Floor, New York, Ny 100103
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Fiscal year20212022
Operating income-$1.8M2
Income before tax$1.1M2
Income tax$542.7K2
Net income$599.2K2

Compare DA32 Life Science Tech Acquisition Corp. with another company

Corporate structure

DA32 Life Science Tech Acquisition Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of DA32 Life Science Tech Acquisition Corp.

  • DA32 Life Science Tech Acquisition Corp. New York, New York

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What DA32 Life Science Tech Acquisition Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.9M7 Dec 31, 2021

Leadership

Who has led DA32 Life Science Tech Acquisition Corp., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Steven J. Kafka2021

Chief financial officer

  1. Chris Wolfe2021
2025
Board members and other officers (8)

Timeline

  1. Jul 21, 20238-K Regulation FD disclosure18
  2. Jul 27, 2021New chief executive Steven J. Kafka becomes CEO9

Filings

31 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 1 major events, 3 insider forms, 19 large holders, 1 other. The latest 20:

  1. Feb 7, 2024SC 13G/A EDGAR
  2. Sep 11, 2023SC 13G/A 13G/A DALS EDGAR
  3. Aug 10, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  4. Aug 10, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  5. Aug 8, 2023SC 13G/A EDGAR
  6. Aug 8, 202315-12G EDGAR
  7. Aug 4, 2023SC 13D/A ARCH VENTURE FUND XI, L.P. - DA32 LIFE SCIENCE -- SCH 13G/A(#1) EDGAR
  8. Aug 2, 2023SC 13D/A EDGAR
  9. Aug 1, 20234 EDGAR
  10. Aug 1, 2023SC 13D/A EDGAR
  11. Aug 1, 2023SC 13D/A EDGAR
  12. Jul 21, 20238-K EDGAR
  13. May 15, 2023SC 13G/A EDGAR
  14. May 12, 202310-Q EDGAR
  15. Apr 10, 2023SC 13G DALS 13G EDGAR
  16. Mar 29, 202310-K EDGAR
  17. Feb 14, 2023SC 13G/A EDGAR
  18. Feb 6, 2023SC 13G/A SEC SCHEDULE 13G EDGAR
  19. Feb 6, 2023SC 13G/A EDGAR
  20. Jan 31, 2023SC 13G/A EDGAR

The 31 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How DA32 Life Science Tech Acquisition Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARDA32 Life Science Tech Acquisition Corp.1
  • CIK0001863294
  • Employer ID (EIN)86-33529881
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)6770 Blank Checks1
  • SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
  • Business address345 Park Avenue South, 12Th Floor, New York, NY 100101
  • Phone(212) 551-16001
  • Public float$161.3M as of Jun 30, 20222
  • On EDGAR sinceMay 28, 20211
  • Filings77 in all: 4 (14), 3 (12), SC 13G/A (11), SC 13G (7), 10-Q (5), CORRESP (4), SC 13D (4), SC 13D/A (4)1
    All 20 form types

    8-K (3), 10-K (2), UPLOAD (2), 15-12G (1), 25-NSE (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), EFFECT (1), S-1 (1), S-1/A (1)

  • Latest filingsAnnual report (10-K) Mar 29, 2023
    Quarterly report (10-Q) May 12, 2023
    Latest 8-K (8-K) Jul 21, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30